Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):20–27. doi: 10.1097/QAI.0000000000001766

Figure 2.

Figure 2

Cumulative incidence of HIV and HSV-2 by time since study enrollment and attendance in a Monte Carlo sample of 10,000, accounting for confounding*

*Confounders included: baseline age, time of survey, visit number, baseline intervention arm, baseline SES, depression, anxiety, alcohol use, baseline orphan status; HSV-2 was also included for the HIV outcome